ADMINISTRATION OF PROSTAGLANDIN-E1 IN NEONATES WITH CRITICAL CONGENITAL CARDIAC DEFECTS

被引：53

作者：

LEWIS, AB ^{[1
]}

TAKAHASHI, M ^{[1
]}

LURIE, PR ^{[1
]}

机构：

[1] UNIV SO CALIF, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90007 USA

来源：

关键词：

D O I：

10.1016/S0022-3476(78)81171-8

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：481 / 485

页数：5

共 16 条

[1] CASSIN S, 1975, P SOC EXP BIOL MED, V148, P584
[2] CHRISTENSEN NC, 1975, LANCET, V2, P406
[3] PROSTAGLANDINS AND CENTRAL NERVOUS-SYSTEM
COCEANI, F
[J]. ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (01) : 119 - 129
[4] RESPONSE OF DUCTUS-ARTERIOSUS TO PROSTAGLANDINS
COCEANI, F
OLLEY, PM
[J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1973, 51 (03) : 220 - 225
[5] ELLIOTT RB, 1975, LANCET, V1, P140
[6] NEUROLOGICAL AND ELECTROENCEPHALOGRAPHIC CHANGES IN NEWBORNS TREATED WITH PROSTAGLANDINS-E1 AND E2
FARIELLO, R
OLLEY, PM
COCEANI, F
[J]. PROSTAGLANDINS, 1977, 13 (05): : 901 - 907
[7] HEYMANN MA, 1977, PEDIATRICS, V59, P325
[8] LANG P, 1977, J PEDIATR-US, V91, P805, DOI 10.1016/S0022-3476(77)81047-0
[9] LEWIS AB, PEDIATRICS
[10] Nakano J, 1971, Mod Concepts Cardiovasc Dis, V40, P49